Literature DB >> 21326974

Chronic lymphocytic leukaemia: a-twenty-years experience and problems in Ile-Ife, South-Western Nigeria.

L Salawu1, R A Bolarinwa, M A Durosinmi.   

Abstract

AIM: To investigate the usefulness of some clinical and laboratory parameters in assessing the prognosis and survival of CLL in a resource-limited setting.
METHODS: Between September 1986 and March 2007, 79 consecutive patients were retrospectively studied. Diagnosis was based on clinical and haematological findings.
RESULTS: A total of 79 patients, aged 30 to 81 (median = 60) years were managed. There were 34 males and 45 females (ratio = 0.8:1). About 86.1% were aged above 50 years. Massive splenomegaly and hepatomegaly were recorded in 70.9% and 29.1% of patients, respectively. More than 63% presented in stage C. Anaemia was recorded in 74.7%. Haematocrit correlated negatively with WBC but positively with platelet count. The spleen correlated positively with liver. The overall survival at 2 years was 70.2%. Logistic regression showed that younger age, male sex, higher haematocrit, and lower platelet count improved survival, while lower WBC, moderate hepatomegaly and splenomegaly conferred survival advantage.
CONCLUSION: It could be concluded that massive splenomegaly is a common finding in the majority of our patients. Non availability of immunophenotyping facility is a major constraint.

Entities:  

Keywords:  CLL; diagnostic problems; resource-limited setting

Mesh:

Year:  2010        PMID: 21326974      PMCID: PMC2956293     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  16 in total

1.  [Importance of prognostic factors in patients with chronic B-lymphocytic leukemia at the time of diagnosis].

Authors:  E Cmunt; K Michalová; L Sindelárová; J Karban; Z Zemanová; S Kurková; J Brezinová; J Schwarz; Z Bosáková
Journal:  Sb Lek       Date:  2002

2.  Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century.

Authors:  Hermann Brenner; Adam Gondos; Dianne Pulte
Journal:  Blood       Date:  2008-02-28       Impact factor: 22.113

3.  Genotypic characterization and multivariate survival analysis of chronic lymphocytic leukemia in Taiwan.

Authors:  P M Chen; S H Lin; S F Fan; T J Chiou; R K Hsieh; I T Yu; J H Liu
Journal:  Acta Haematol       Date:  1997       Impact factor: 2.195

4.  Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.

Authors:  F R Mauro; R Foa; R Cerretti; D Giannarelli; S Coluzzi; F Mandelli; G Girelli
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

5.  Prognosis related to staging systems for chronic lymphocytic leukemia.

Authors:  J R de Faria; J S de Oliveira; R M Delbone de Faria; M R Silva; S Goihman; M Yamamoto; J Kerbauy
Journal:  Sao Paulo Med J       Date:  2000-07-06       Impact factor: 1.044

Review 6.  Chronic lymphocytic leukaemia: prognostic factors and natural history.

Authors:  E Montserrat; C Rozman
Journal:  Baillieres Clin Haematol       Date:  1993-12

7.  Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.

Authors:  D Catovsky; J Fooks; S Richards
Journal:  Br J Haematol       Date:  1989-06       Impact factor: 6.998

8.  The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.

Authors:  Clive S Zent; Wei Ding; Susan M Schwager; Megan S Reinalda; James D Hoyer; Diane F Jelinek; Renee C Tschumper; Deborah A Bowen; Timothy G Call; Tait D Shanafelt; Neil E Kay; Susan L Slager
Journal:  Br J Haematol       Date:  2008-03-27       Impact factor: 6.998

9.  Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul.

Authors:  Omer Nuri Pamuk; Gülsüm Emel Pamuk; Teoman Soysal; Seniz Ongören; Zafer Başlar; Burhan Ferhanoğlu; Yildiz Aydin; Birsen Ulkü; Gulten Aktuğlu; Nuran Akman
Journal:  South Med J       Date:  2004-03       Impact factor: 0.954

10.  Prognostic value of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL).

Authors:  G De Rossi; L Granati; G Girelli; G Gandolo; P Perrone; M Martelli; L Conti; R Marini; D Pastorelli; S Coluzzi; P Niscola; F Pizzo; F Mandeli
Journal:  Tumori       Date:  1991-04-30
View more
  7 in total

1.  Response to Comment by Amato T. et al.

Authors:  Ilaria Del Giudice; Robin Foà
Journal:  Haematologica       Date:  2019-11       Impact factor: 9.941

2.  IGHV1 status in chronic lymphocytic leukemia identify ethnic groups with an aggressive clinical course (Comment to Giudice ID, Foà R. Haematologica. 2019;104(2):219-221).

Authors:  Teresa Amato; Massimo Granai; Lorenzo Leoncini; Cristiana Bellan
Journal:  Haematologica       Date:  2019-10       Impact factor: 9.941

3.  Presenting features and treatment outcomes of chronic lymphocytic leukaemia in a resource poor Southern Nigeria.

Authors:  Anazoeze Jude Madu; Kaladada Korubo; Augustine Okoye; Ifeoma Ajuba; Augustine N Duru; Angela O Ugwu; Oji Nnachi; Helen Chioma Okoye
Journal:  Malawi Med J       Date:  2019-06       Impact factor: 0.875

4.  Chronic Lymphocytic Leukemia: Prognostic Factors at Presentation in a Resource-Limited Center.

Authors:  Kaladada Ibitrokoemi Korubo; Uchechukwu Prince Okite; Sampson Ibekwe Ezeugwu
Journal:  JCO Glob Oncol       Date:  2021-01

5.  Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study.

Authors:  Yang Ou; Yichen Long; Lili Ji; Yanxia Zhan; Tiankui Qiao; Xiangdong Wang; Hao Chen; Yunfeng Cheng
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

6.  Characteristics of chronic lymphocytic leukemia in Senegal.

Authors:  Abibatou Sall; Awa Oumar Touré; Fatimata Bintou Sall; Moussa Ndour; Seynabou Fall; Abdoulaye Sène; Blaise Félix Faye; Moussa Seck; Macoura Gadji; Tandakha Ndiaye Dièye; Claire Mathiot; Sophie Reynaud; Saliou Diop; Martine Raphaël
Journal:  BMC Hematol       Date:  2016-04-23

7.  The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL): A protocol for a systematic review and meta-analysis of randomized controlled trials.

Authors:  Aviwe Ntsethe; Phiwayinkosi Vusi Dludla; Tawanda Maurice Nyambuya; Siphamandla Raphael Ngcobo; Bongani Brian Nkambule
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.